Research Article |
Corresponding author: Ghaidaa Sulaiman Hameed ( ghaidaahameed@uomustansiriyah.edu.iq ) Academic editor: Denica Momekova
© 2022 Ghaidaa Sulaiman Hameed, Masar Basim Mohsin Mohamed, Mohanad Naji Sahib.
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Citation:
Sulaiman Hameed G, Basim Mohsin Mohamed M, Naji Sahib M (2022) Binary or ternary mixture of solid dispersion: Meloxicam case. Pharmacia 69(3): 801-808. https://doi.org/10.3897/pharmacia.69.e86744
|
The present work was carried out to assess the value of adding water insoluble polymer to meloxicam amorphous solid formulation (ASD). Meloxicam was mixed with polyvinylpyrrolidone (PVP) (1:1 ratio) as a binary mixture and with PVP and ethyl cellulose (1:1:1 ratio) as a ternary mixture. Solvent evaporation method was used to prepare ASD formulations. The differential scanning calorimetry, powder X-Ray diffraction, Cambridge Structural Database and in-vitro dissolution were performed to assess the formulas. The results showed that the addition of insoluble polymer could prevent the recrystallization process during ASD formation. However, the binary mixture showed higher drug release percentage than the ternary mixture. Therefore, a rational amount of insoluble polymer could be considered to control recrystallization and manipulate drug release from ASD formulations.
Cambridge structure database, Meloxicam, Solid dispersion, Solvent evaporation
Drug solubility is still a challenge for many formulators. Hence, many methods have been adapted to increase the solubility such as prodrugs, salt formation, micronization, and amorphous solid formation. The last method showed an increase in the solubility of many drugs such as indomethacin, ketoprofen and griseofulvin (
The presence of water soluble polymer is important to enhance drug water solubility (
Meloxicam (MEL) is a class II drug of the biopharmaceutical classification system (low aqueous solubility and high permeability) (
Meloxicam was kindly donated form Al-Furat factory, Baghdad-Iraq, ethyl cellulose from Provizer pharma India, sodium lauryl sulphate (SLS) form Fluka chemical. Buchs, sodium dihydrogen orthophosphate dihydrate, di-sodium hydrogen orthophosphate dihydrate and methanol form Thomas baker, India. Polyvinylpyrrolidone K30 (PVP) was purchased from HiMedia Laboratories (India).
Physical mixtures were prepared by mixing meloxicam with PVP (1:1) and with PVP:ethyl cellulose (1:1:1). The mixtures were triturated by hand using a mortar and pestle for 5 minutes at room temperature. Solid dispersion formulations were prepared by the solvent evaporation method. The required amount of drug and carrier in 1:1 ratios is weighed and blended in a porcelain dish. Then, the mixtures were dissolved in methanol. Afterward, the solvent was removed under reduced pressure for 20 min at 70 °C using a rotary vacuum evaporator. The obtained solid dispersions were pulverized in a mortar and sieved, then stored in a desiccator to be utilized for further characterizations.
To assess the probability of bond formation between all materials, the H-bond in crystal structure was evaluated using Cambridge Structural Database (CSD) (Version 5.42, CCDC, Cambridge, UK). ConQuest was used to form the queries (version 3 CSDC, Cambridge, UK).
All samples were examined by DSC 60 (Shimadzu, Japan). The samples were sealed in an aluminum pans (5–6 mg) and subject to heat (35 °C to 400 °C) at rate of 10 °C/min under an argon atmosphere.
The X-ray diffraction was measured using a powder X-ray diffractometer. The operating conditions were: current 30 mA, voltage 40 kV, and 1/min scanning speed with a range of 10–90° (2θ). The Degree of Crystallinity was calculated using Origin Lab software.
Dissolution experiments for all formulations which equivalent to 15mg meloxicam (meloxicam powder, physical mixtures, binary and ternary mixtures) were performed using Cosmolab Type II dissolution apparatus, India, at 37 °C (100 rpm). The dissolution media was 900 mL water with SLS (0.2%) to ensure sink condition. At predetermined time intervals, 5 mL of samples were withdrawn and analyzed using UV-spectrophotometer (λmax = 363 nm). The same volume (maintained at 37 °C) was added to the dissolution media to maintain constant volume and sink condition. Model dependent and independent methods were used to compare meloxicam dissolution profiles. The model-dependent approaches included the zero order, the first order, the Hixson-Crowell, the Higuchi and the Weibull models. While the model independent approaches included Fit factors (difference factor f1, and the similarity factor f2), dissolution efficiency % (DE%), mean dissolution time (MDT). The results were compared using one-way analysis of variance (ANOVA) when applicable (SPSS Statistics 22).
Stabilization of amorphous solid dispersions (ASD) is largely depend on specific drug-polymer interaction (
Fig.
On the other hand, the physical mixture of meloxicam and PVP (Fig.
Moreover, Fig.
The DSC results revealed the amorphous formation of the binary and ternary mix. However, it did not confirm the stability of the formulations. The recrystallization process can be assessed quantitatively by calculation the Degree of Crystallinity (DC). Fig.
The physical mixture of meloxicam and PVP showed a reduction in the intensity of Braggs peaks due to the dilution effect of the polymer (
The overall results suggested that the ternary mixture had better stability than the binary mixture. Moreover, the results consistent with the previous report (
Fig.
The release rate of the physical mixture of meloxicam with PVP was increased from 40% to about 60% due to the presence of PVP which is water soluble polymer. After solvent evaporation, the release rate increased to about 90% which is consistent with the previous report (
The dissolution profiles corresponding to binary and ternary mixtures showed Hixon-Crowell model with the higher determination coefficients (r2) and smallest AIC values (Table
Model | Statistics | Formulations | |||||
---|---|---|---|---|---|---|---|
I | II | III | IV | V | VI | ||
Zero order | r2 | 0.816 | 0.968 | 0.995 | 0.962 | 0.985 | 0.982 |
k | 0.223 | 0.453 | 0.330 | 0.353 | 0.607 | 0.480 | |
AIC | 35.33 | 31.84 | 14.92 | 29.57 | 30.71 | 28.39 | |
MSC | 1.12 | 2.86 | 4.62 | 2.70 | 3.60 | 3.46 | |
First order | r2 | 0.861 | 0.979 | 0.996 | 0.986 | 0.988 | 0.996 |
k | 0.004 | 0.008 | 0.004 | 0.007 | 0.017 | 0.010 | |
AIC | 33.33 | 28.96 | 10.69 | 22.78 | 27.80 | 18.87 | |
MSC | 1.41 | 3.28 | 4.94 | 3.72 | 3.89 | 4.82 | |
Hixon-Crowell | r2 | 0.847 | 0.980 | 0.9943 | 0.999 | 0.994 | 0.996 |
k | 0.001 | 0.002 | 0.001 | 0.632 | 0.004 | 0.003 | |
AIC | 34.04 | 28.44 | 13.06 | 8.99 | 23.03 | 17.40 | |
MSC | 1.306 | 3.35 | 4.59 | 5.69 | 4.61 | 5.03 | |
Higuchi | r2 | 0.888 | 0.965 | 0.993 | 0.992 | 0.994 | 0.995 |
k | 4.275 | 6.098 | 4.150 | 5.64 | 8.315 | 6.863 | |
AIC | 32.00 | 32.50 | 15.32 | 18.63 | 23.82 | 19.53 | |
MSC | 1.62 | 2.77 | 4.36 | 4.31 | 4.53 | 4.73 | |
Weilbull | r2 | 0.966 | 0.9818 | 0.996 | 0.977 | 0.995 | 0.996 |
β | 0.284 | 1.279 | 0.903 | 0.002 | 1.660 | 1.144 | |
AIC | 25.51 | 29.89 | 13.54 | 25.95 | 24.26 | 19.57 | |
MSC | 2.54 | 3.15 | 4.77 | 3.22 | 4.43 | 4.72 |
I meloxicam powder; II solvent evaporated meloxicam powder; III physical mixture of meloxicam-PVP; IV solvent evaporated meloxicam-PVP mixture; V physical mixture of meloxicam-PVP- ethyl cellulose; VI solvent evaporated of meloxicam-PVP- ethyl cellulose mixture; red color bold font indicate model fit.
Mean dissolution time and dissolution efficiency of different formulations.
Variables | Formulations | |||||
---|---|---|---|---|---|---|
I | II | III | IV | V | VI | |
Mean dissolution time (MDT)* | 25.47±0.84† | 37.36±1.01† | 42.02±2.22‡ | 44.65±0.70‡ | 43.85±1.89‡ | 45.52±1.70‡ |
Dissolution efficiency (DE) | 0.36±0.02† | 0.41±0.01*‡ | 0.59±0.01‡ | 0.46±0.16† | 0.42±0.01*† | 0.29±0.02† |
I meloxicam powder; II solvent evaporated meloxicam powder; III physical mixture of meloxicam-PVP; IV solvent evaporated meloxicam-PVP mixture; V physical mixture of meloxicam-PVP- ethyl cellulose; VI solvent evaporated of meloxicam-PVP- ethyl cellulose mixture; † significant differences between formulations (P < 0.05); ‡ insignificant differences between formulations (P > 0.05); * insignificant difference between two formulations (P > 0.05).
Ternary mixture from hydrophilic and hydrophobic polymer can be used in a proper ratio to ensure both solubility and stability of amorphous solid dispersion formulation. The miscibility between the polymer mixtures is important to avoid phase separation in pharmaceutical pre-formulation which can be easily detected by CSDB through H-bond formation. From this study, the results acquired from DSC, XRPD analysis confirmed the conversion of meloxicam from crystalline to amorphous state. Moreover, the dissolution profile was greatly enhanced compared to meloxicam powder. Consequently, it was concluded that the addition of insoluble polymer could prevent the recrystallization process during ASD formation with an acceptable dissolution properties.
The author reports no conflicts of interest in this work.